1-deoxynojirimycin has been researched along with Brain Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pastores, GM | 1 |
1 review(s) available for 1-deoxynojirimycin and Brain Disorders
| Article | Year |
|---|---|
Miglustat: substrate reduction therapy for lysosomal storage disorders associated with primary central nervous system involvement.
Topics: 1-Deoxynojirimycin; Animals; Brain; Brain Diseases; Enzyme Inhibitors; Humans; Lysosomal Storage Diseases | 2006 |